Breast inflammation: indications for MRI and PET-CT.
Breast inflammation: indications for MRI and PET-CT.
复制标题
DOI：
10.1016/j.diii.2011.12.004
复制
发表时间：
2012-02-01
影响因子：
5.5
通讯作者：
de Kerviler, E
中科院分区：
文献类型：
--
作者：
de Bazelaire, C;Groheux, D;de Kerviler, E
治疗前，乳腺MRI不应用于炎性乳腺癌和急性乳腺炎（AM）之间的鉴别诊断。当乳腺炎症状持续10至15天的良好管理的药物治疗后，MRI可以进行除了超声检查，乳房X光检查和采取组织学样本，以消除炎性乳腺癌（IBC）。对于分期，MRI似乎有助于寻找对侧病变，PET-CT用于寻找有关远端转移的信息，在某些中心，用于寻找有关局部/区域淋巴结初始扩展的信息，这将指导照射野（因为患者在新辅助化疗后可能变为淋巴结阴性）。MRI和PET-CT似乎是有用的早期检测患者反应不佳的新辅助化疗，使后者可以迅速修改。
Breast MRI should not be used for differential diagnosis between inflammatory breast cancer and acute mastitis (AM) prior to treatment. When mastitis symptoms persist after 10 to 15 days of well-managed medical treatment, MRI may be performed in addition to an ultrasound examination, a mammogram and to taking histological samples, in order to eliminate inflammatory breast cancer (IBC). For staging, MRI would seem to be useful in looking for a contralateral lesion, PET-CT for finding information about remote metastases and in certain centres, for information about the initial extension to local/regional lymph nodes, which would guide the fields of irradiation (since patients can become lymph node negative after neoadjuvant chemotherapy). MRI and PET-CT seems to be useful for early detection of patients responding poorly to neoadjuvant chemotherapy so that the latter may be rapidly modified.